U.S. markets closed

Cannara Biotech Inc. (LOVFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1225+0.0012 (+0.95%)
At close: 1:23PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1213
Open0.1246
BidN/A x N/A
AskN/A x N/A
Day's Range0.1196 - 0.1251
52 Week Range0.0088 - 0.1973
Volume33,145
Avg. Volume54,792
Market Cap90.68M
Beta (5Y Monthly)1.79
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Cannara Biotech Launches Cannabis Brand Portfolio Now Available in Quebec - Tribal, Nugz, Orchid CBD
      CNW Group

      Cannara Biotech Launches Cannabis Brand Portfolio Now Available in Quebec - Tribal, Nugz, Orchid CBD

      Cannara's three new brands – Tribal, Nugz and Orchid CBDMONTREAL, Feb. 25, 2021 /CNW/ - Cannara Biotech Inc.

    • Cannara Biotech Inc. Reports Q1 2021 Financial Results
      CNW Group

      Cannara Biotech Inc. Reports Q1 2021 Financial Results

      \- Expects to generate revenue from letter of intent with the Société québécoise du cannabis by end of February or early March 2021 -MONTREAL, Jan. 29, 2021 /CNW/ - Cannara Biotech Inc.

    • Cannara Biotech Receives Sales Licence from Health Canada
      PR Newswire

      Cannara Biotech Receives Sales Licence from Health Canada

      Cannara Biotech Inc.("Cannara" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB) is pleased to announce that, through its wholly-owned subsidiary, Cannara Biotech (Quebec) Inc., it has received approval from Health Canada to amend its license to permit the sale of dried cannabis products to provincially authorized distributors and retailers nationwide. As revenue steadily grows over the next 12 months, Cannara expects rapid growth in profitability and cashflow given its lean operating structure and production cost advantage.